PPD

“Where others see challenges, I see opportunities. This is what makes me rare.” Meet Brady Chan, 14, who lives with spinal muscular atrophy, a genetic disease affecting the central nervous system, peripheral nervous system and voluntary muscle movement. His mom, Mimi, global market development marketing manager, shares how the proverb of “it takes a village” took on greater meaning once Brady was diagnosed. “Moving from the patient side to the research side at Thermo Fisher Scientific has introduced me to the dedicated village working to change the lives of those with rare diseases,” Mimi said. “Through my work, I hope my son sees the passion my colleagues and I share in building a future where rare diseases no longer limit anyone’s quality of life – and that this continues to drive his hope for a brighter future.” Learn more about our commitment to rare disease research. » https://bit.ly/4bmDTx1 #RareDiseaseDay #ShareYourColors #ShareYourColours

It’s important for your CRO to continually assess and invest in capabilities that help drive the success of your clinical program. We are forging a path of innovation through targeted upgrades and the deployment of new systems to support the needs of current and future research. Learn more » https://bit.ly/4idYSoa

We are excited to be attending DIA Medical Affairs and Scientific Communications Forum on March 10-12 in Boston! Our team will be participating in sessions on Monday, March 10, and Tuesday, March 11. Can’t make the sessions? Visit us at booth 300 to discover how our bespoke, end-to-end medical information solutions can support your unique needs. » https://bit.ly/4koGCKH #MedicalWriting #MedicalAffairs #ScientificCommunications #MedicalSolutions #MedicalInformation

The Sustainable Markets Initiative's Health Systems Task Force released an Open Letter, signed by the CEOs of seven global health care companies, calling on members of the clinical trial community to support efforts to measure and reduce greenhouse gas emissions from clinical trials. We are uniquely positioned to meet or exceed this calling, and we encourage the pharmaceutical industry and biotech community to join our efforts to measure and reduce the emissions of clinical trial activities. We have made significant investments in our data capabilities to measure the emissions of clinical trial activities, and we also offer our customers decarbonization options, such as sustainable aviation fuel for shipping, electric vehicle patient travel, data-driven opportunities for waste reduction and more. Thermo Fisher Scientific supports the urgent calls for action from scientists around the world to address climate change and has committed to achieving net-zero emissions by 2050.

Discover the latest insights on executing successful radiopharmaceutical clinical trials. Our experts will share best practices and strategies for effective trial execution, ensuring you stay ahead in the field. Don't miss this opportunity to learn from industry leaders and enhance your expertise. Join us live on LinkedIn on Monday, Feb. 24 at 11 a.m. ET. » https://bit.ly/41nM3lg #radiopharmaceutical #clinicaltrials

Are delays in clinical trials draining your resources? Supercharge your success by unlocking the potential of AI, leveraging CRO and CDMO integrated solutions, and optimizing site selection. Discover the ultimate guide to accelerating your trials and revolutionize your clinical development strategy now. » https://bit.ly/41jq6nA #clinicaltrials #clinicaldevelopment

We’re excited about DCAT Week 2025 next month! Don’t miss the chance to connect with our experts at #DCATWeek 2025 in New York City and discover how our #GMPlab services and #CRO solutions can help biotechs get treatments to patients faster. 📅 Schedule a meeting with us » https://bit.ly/3CURWNE #DCAT #DCATWeek2025

Successful participation in clinical trials will lead to more effective treatments and interventions for our growing elderly population. Our experts outline how to overcome common challenges associated with clinical research in elderly patients. » https://bit.ly/4gL3UXR

Rose Blackburne, MD, MBA joined industry peers for a panel discussion on advancing treatments for pediatric patients during J.P. Morgan Healthcare week in San Francisco. Here are 4️⃣ vital takeaways: 📋 Regulatory initiatives spur pediatric drug and device development — for instance, the Pediatric Research Equity Act (PREA) requires developers to conduct separate, dedicated studies for children. This has led to a significant increase in the number of pediatric clinical trials, resulting in new approvals and expanded therapies and labels for children. 📈 Investing in neonatal and pediatric products is life-changing for patients and families, impacting patients' quality and length of life. 📱 Using innovative, digital technologies (e-consents, wearables, digital diaries, home visits, etc.) to conduct decentralized trials expands access to clinical trials for pediatric patients by decreasing the logistical burdens of trial participation for the patient and their patients/caregivers. 😷 Children are being impacted by diseases other than childhood diseases - obesity, asthma, neurologic disorders, rare diseases — all of which expand the opportunity to develop pediatric treatments.

As part of our commitment to #sustainability, we have renewed our partnership with One Tree Planted, a non-profit organization focused on global reforestation. One Tree Planted has planted more than 100 million trees around the world since 2014. Through our partnership with One Tree Planted, we plant a tree for every patient enrolled at a PPD site. Together, we aim to restore forests, create biodiverse habitats and raise awareness about the importance of sustainable #clinicaltrials. 🌱 Learn more » https://bit.ly/3qa32bb